France Nixes Teva Unit's Relief Bid In Plavix Case

Law360, New York (May 18, 2010, 5:34 PM EDT) -- France's antitrust watchdog refused a Teva Pharmaceutical Industries Ltd. unit's request for emergency relief against Sanofi-Aventis SA on Tuesday, but said it would continue to probe the generic-drug maker's claims that the pharmaceutical giant unfairly suggested that rival generic copies of its blood-thinning drug Plavix were less safe than its own blockbuster version.

The French Competition Authority denied Teva Health's request for provisional measures, noting that the alleged situation was not an emergency because generic versions of the blood thinner are already widely used as a...
To view the full article, register now.